ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 62.84998 | 0 | male | 0 | 5 | 2,029 | Lung Cancer | Cancer | 0 | 11 | $11-$25k | 0 | 9,715 | null | null | 7 | other | 33.898438 | 20 | 0.262939 | 0.036995 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | no dnr | 5 | 97 | 6 | 69 | 22 | 36 | 388 | 1.799805 | 0.199982 | 1.199951 | 141 | 7.459961 | null | null | null | 7 | 7 | null | 7 |
2 | 60.33899 | 1 | female | 1 | 4 | 4 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 44 | 34,496 | null | null | 29 | white | 52.695313 | 74 | 0.001 | 0 | 3 | 0 | 0 | no | 0 | 0 | null | null | 43 | 17.097656 | 112 | 34 | 34.59375 | 98 | null | null | 5.5 | 132 | 7.25 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3 | 52.74698 | 1 | female | 0 | 17 | 47 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 41,094 | null | null | 13 | white | 20.5 | 45 | 0.790894 | 0.664917 | 4 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 17 | 70 | 8.5 | 88 | 28 | 37.39844 | 231.65625 | null | 2.199707 | 2 | 134 | 7.459961 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
4 | 42.38498 | 1 | female | 0 | 3 | 133 | Lung Cancer | Cancer | 2 | 11 | under $11k | 0 | 3,075 | null | null | 7 | white | 20.097656 | 19 | 0.698975 | 0.411987 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 3 | 75 | 9.099609 | 88 | 32 | 35 | null | null | null | 0.799927 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5 | 79.88495 | 0 | female | 0 | 16 | 2,029 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 50,127 | null | null | 18.666656 | white | 23.5 | 30 | 0.634888 | 0.532959 | 3 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 16 | 59 | 13.5 | 112 | 20 | 37.89844 | 173.3125 | null | null | 0.799927 | 143 | 7.509766 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
6 | 93.01599 | 1 | male | 1 | 4 | 4 | Coma | Coma | 1 | 14 | null | 55 | 6,884 | null | null | 5 | white | 19.398438 | 27 | 0.284973 | 0.214996 | 1 | 0 | 0 | no | 0 | 0 | no dnr | 4 | 110 | 10.398438 | 101 | 44 | 38.39844 | 266.625 | null | null | 0.699951 | 140 | 7.65918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
7 | 62.37097 | 1 | male | 0 | 9 | 659 | CHF | COPD/CHF/Cirrhosis | 1 | 14 | $25-$50k | 0 | 30,460 | null | null | 8 | white | 17.296875 | 46 | 0.892944 | 0.820923 | 1 | 0 | 0 | no | null | 0.7 | no dnr | 9 | 78 | 11.699219 | 120 | 28 | 37.39844 | 309.5 | 4.799805 | 0.399963 | 1.599854 | 132 | 7.479492 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
8 | 86.83899 | 1 | male | 0 | 7 | 142 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 26 | 30,460 | null | null | 6.5 | white | 21.597656 | 53 | 0.670898 | 0.498962 | 1 | 1 | 0 | no | 0.8 | 0.4 | no dnr | 7 | 72 | 13.599609 | 100 | 26 | 37.59375 | 404.75 | null | null | 2 | 139 | 7.509766 | null | null | null | null | 0 | null | 0 |
9 | 85.65594 | 1 | male | 0 | 12 | 63 | Lung Cancer | Cancer | 2 | 12 | null | 26 | null | null | null | 8.5 | black | 15.898438 | 17 | 0.570923 | 0.248993 | 1 | 0 | 1 | metastatic | 0.05 | 0.000125 | dnr after sadm | 2 | 97 | 9.699219 | 56 | 20 | 36.59375 | 357.125 | null | 0.399963 | 1 | 143 | 7.449219 | null | null | null | null | 7 | null | 7 |
10 | 42.25897 | 1 | female | 0 | 8 | 370 | Colon Cancer | Cancer | 0 | 11 | $25-$50k | 0 | 9,914 | null | null | 8 | hispanic | 2.299805 | 9 | 0.952881 | 0.887939 | 1 | 0 | 0 | metastatic | null | null | no dnr | 8 | 84 | 11.298828 | 94 | 20 | 38.19531 | null | 4.699219 | 0.199982 | 0.799927 | 139 | null | null | null | null | 0 | null | null | 0.4948 |
11 | 47.94498 | 1 | male | 0 | 7 | 114 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 15,558 | null | null | 12.5 | white | 14.599609 | 14 | 0.935913 | 0.890991 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 7 | 70 | 10.898438 | 105 | 24 | 36.5 | null | 4.199219 | 0.5 | 1 | 134 | null | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
12 | 59.20099 | 1 | male | 1 | 13 | 13 | Lung Cancer | Cancer | 0 | 14 | null | 0 | 29,388 | null | null | 8 | white | 16.398438 | 17 | 0.731934 | 0.461975 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 12 | 77 | 10.798828 | 90 | 22 | 36.39844 | null | null | null | 1.099854 | 136 | null | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
13 | 29.002 | 1 | female | 0 | 4 | 160 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 16 | $11-$25k | 0 | 4,353 | null | null | 8 | white | 26.898438 | 30 | 0.850952 | 0.754883 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 56 | 5.5 | 56 | 20 | 37.19531 | null | 2.899902 | 6.099609 | 0.699951 | 130 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
14 | 68.14197 | 1 | male | 0 | 8 | 1,866 | CHF | COPD/CHF/Cirrhosis | 0 | 12 | $11-$25k | 0 | 19,783 | null | null | 16 | white | 20.296875 | 34 | 0.849976 | 0.75293 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 8 | 68 | 9.398438 | 80 | 22 | 36 | null | null | 0.599976 | 2.599609 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
15 | 43.53998 | 0 | female | 0 | 115 | 2,022 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 706,577 | 390,460.5 | null | 38.25 | white | 30.5 | 39 | 0.590942 | 0.481995 | 148 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 115 | 67 | 24.597656 | 172 | 20 | 38.79688 | 113.32812 | null | null | 0.599976 | 134 | 7.399414 | null | null | null | null | null | SIP>=30 | 2.76416 |
16 | 58.823 | 1 | female | 0 | 7 | 503 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 10,758 | null | null | 10 | white | 7.799805 | 11 | 0.856934 | 0.682983 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 7 | 97 | 15.898438 | 92 | 20 | 37.19531 | null | 4.299805 | 0.199982 | 0.799927 | 134 | null | null | null | null | 2 | 0 | null | 0 |
17 | 45.418 | 1 | male | 0 | 7 | 827 | Lung Cancer | Cancer | 2 | null | null | 0 | 8,400 | null | null | 7 | white | 16 | 4 | 0.768921 | 0.521973 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 97 | 10.798828 | 100 | 24 | 37.29688 | 585.125 | null | 0.299988 | 1.099854 | 137 | 7.489258 | null | null | null | null | null | null | 3.351563 |
18 | 63.66299 | 1 | female | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 22 | $25-$50k | 26 | 283,303 | 156,674.125 | null | 40 | white | 40.296875 | 58 | 0.212982 | 0.116989 | 13 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 12 | 69 | 30.097656 | 108 | 22 | 36.69531 | 155.53125 | 2.899902 | 14 | 2.899902 | 130 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
19 | 31.84399 | 1 | male | 1 | 15 | 15 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | under $11k | 0 | 27,985 | 17,528.4375 | null | 10 | white | 33.898438 | 42 | 0.73291 | 0.581909 | 1 | 0 | 0 | no | null | null | dnr after sadm | 12 | 83 | 5 | 100 | 24 | 37.39844 | null | 1.699951 | 12.798828 | 0.299988 | 122 | null | null | null | null | 7 | 7 | <2 mo. follow-up | 7 |
20 | 55.13797 | 1 | male | 0 | 10 | 179 | CHF | COPD/CHF/Cirrhosis | 1 | 8 | $11-$25k | 0 | 18,191 | null | null | 14.5 | hispanic | 17.699219 | 25 | 0.904907 | 0.840942 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 10 | 78 | null | 72 | 20 | 36 | null | null | null | 1.5 | 134 | null | null | null | null | 3 | null | no(M2 and SIP pres) | 2.511099 |
21 | 68.25494 | 1 | male | 0 | 7 | 227 | Lung Cancer | Cancer | 0 | 13 | >$50k | 0 | 10,755 | null | null | 8 | white | 5.599609 | 16 | 0.868896 | 0.704956 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 7 | 91 | 5 | 92 | 20 | 36.5 | null | 4.299805 | 0.299988 | 1.199951 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
22 | 48.70398 | 1 | male | 0 | 23 | 30 | Lung Cancer | Cancer | 0 | 16 | null | 0 | 55,384 | 33,002.5 | null | 9.666664 | other | 26.199219 | 35 | 0.535889 | 0.213989 | 1 | 0 | 0 | metastatic | 0.5 | 0.125 | dnr after sadm | 11 | 66 | 12.5 | 125 | 30 | 37 | 170 | null | null | 1 | 133 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 3.263672 |
23 | 49.61298 | 0 | female | 0 | 50 | 2,019 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 542,266 | 288,592.25 | null | 33.75 | white | 31.699219 | 42 | 0.650879 | 0.55188 | 29 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 50 | 67 | 11 | 120 | 48 | 38.89844 | 200 | 2 | 4.099609 | 0.599976 | 130 | 7.399414 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
24 | 50.724 | 1 | female | 0 | 3 | 817 | Lung Cancer | Cancer | 0 | 12 | $25-$50k | 0 | 4,913 | null | null | 10 | asian | 14.199219 | 11 | 0.786987 | 0.552979 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 3 | 71 | 9.798828 | 88 | 24 | 37.39844 | null | null | null | 0.899902 | 141 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.065918 |
25 | 29.36099 | 1 | female | 0 | 4 | 399 | Colon Cancer | Cancer | 0 | 17 | $25-$50k | 0 | 7,792 | null | null | 13 | white | 18.898438 | 10 | 0.853882 | 0.674927 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 4 | 96 | 10.599609 | 112 | 20 | 37 | null | 3.699707 | 1.399902 | 0.599976 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.814941 |
26 | 53.84 | 1 | male | 0 | 7 | 1,064 | COPD | COPD/CHF/Cirrhosis | 1 | null | under $11k | 0 | 9,871 | 6,112.4609 | null | 8 | white | 14.199219 | 16 | 0.939941 | 0.897949 | 1 | 0 | 0 | no | 0.9 | 0.6 | dnr after sadm | 4 | 134 | 7.799805 | 106 | 22 | 37.89844 | 304.125 | 3.799805 | 0.5 | 0.799927 | 141 | 7.379883 | null | null | null | 5 | 4 | no(M2 and SIP pres) | 4 |
27 | 82.41498 | 1 | female | 1 | 5 | 5 | Lung Cancer | Cancer | 0 | null | null | 44 | 7,212 | null | null | 9 | white | 27.296875 | 33 | 0.169983 | 0.011999 | 1 | 0 | 0 | metastatic | null | null | dnr before sadm | -1 | 75 | 6.799805 | 114 | 20 | 37.19531 | null | 3.099609 | null | 1.799805 | 131 | null | null | null | null | null | null | <2 mo. follow-up | 3.704102 |
28 | 27.32399 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 19 | null | 26 | 160,060 | 82,131.25 | null | 39 | asian | 46.796875 | 85 | 0.021 | 0.004999 | 28 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 5 | 77 | 0.099991 | 144 | 36 | 38.89844 | 45 | 2.399902 | 5 | 1.399902 | 147 | 7.30957 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
29 | 30.10799 | 0 | male | 0 | 10 | 2,013 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 37 | 57,611 | 29,342.3906 | null | 30.5 | asian | 22.398438 | 21 | 0.823975 | 0.764893 | 4 | 0 | 0 | no | null | null | no dnr | 10 | 92 | 8.798828 | 112 | 27 | 37.59375 | 225 | null | null | 0.399963 | 134 | 7.459961 | null | null | null | null | null | null | 2.846191 |
30 | 50.37097 | 0 | male | 0 | 105 | 2,013 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 465,380 | 304,749.25 | null | 22.25 | white | 21.296875 | 18 | 0.80896 | 0.690918 | 2 | 0 | 0 | no | null | null | no dnr | 105 | 98 | 8.398438 | 82 | 20 | 37.39844 | 197.5 | 3 | 6.799805 | 0.699951 | 138 | 7.319336 | null | null | null | 3 | 1 | SIP>=30 | 1 |
31 | 74.48297 | 0 | male | 0 | 15 | 2,012 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 0 | 18,134 | 12,751.7344 | null | 7.666664 | white | 16.296875 | 27 | 0.872925 | 0.787964 | 1 | 0 | 0 | no | 0.95 | 0.6 | no dnr | 15 | 111 | 6.899414 | 60 | 32 | 36.79688 | null | 3.799805 | 0.599976 | 1.599854 | 142 | null | null | null | null | 0 | 1 | null | 1 |
32 | 55.73199 | 0 | male | 0 | 13 | 2,012 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 52,092 | 28,262.7031 | null | 17 | hispanic | 31 | 25 | 0.602905 | 0.41394 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 13 | 121 | 19.699219 | 118 | 18 | 37.39844 | 404.75 | 2.199707 | 0.899902 | 0.799927 | 117 | 7.379883 | null | null | null | 7 | 6 | SIP>=30 | 6 |
33 | 77.21295 | 1 | female | 0 | 7 | 51 | COPD | COPD/CHF/Cirrhosis | 2 | 0 | null | 0 | 9,078 | 6,898.4922 | null | 12 | hispanic | 21.796875 | 39 | 0.773926 | 0.638916 | 1 | 0 | 0 | no | 0.75 | 0.75 | dnr after sadm | 2 | 113 | 8.298828 | 93 | 25 | 36.19531 | 250 | null | null | 2.099609 | 145 | 7.269531 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
34 | 61.02399 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 109,627 | 57,442.7812 | null | 30.333328 | white | 26 | 49 | 0.67395 | 0.577881 | 1 | 0 | 0 | no | 0.6 | 0.6 | dnr after sadm | 17 | 80 | 15.398438 | 128 | 30 | 38.5 | 217.5 | 2.299805 | 0.399963 | 2.399902 | 143 | 7.329102 | null | null | null | null | null | <2 mo. follow-up | 2.825195 |
35 | 56.48999 | 1 | female | 0 | 5 | 113 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 38,548 | 20,959.2031 | null | 16 | hispanic | 37.398438 | 53 | 0.546997 | 0.348999 | 4 | 0 | 0 | no | null | null | no dnr | 5 | 38 | null | 92 | 20 | 36 | null | null | null | 6 | 133 | null | null | null | null | null | null | null | 3.098145 |
36 | 57.53299 | 0 | female | 0 | 28 | 2,010 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | under $11k | 0 | 156,556 | 103,090.438 | null | 14.5 | hispanic | 26.597656 | 37 | 0.688965 | 0.522949 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 28 | 77 | 12.199219 | 92 | 18 | 37.59375 | 552.375 | 2.5 | 23.597656 | 0.899902 | 132 | 7.439453 | null | null | null | null | null | no(M2 and SIP pres) | 3.131836 |
37 | 68.98596 | 1 | female | 0 | 4 | 603 | COPD | COPD/CHF/Cirrhosis | 1 | 10 | under $11k | 0 | 5,763 | 2,965.9512 | null | 3 | white | 12.798828 | 21 | 0.910889 | 0.849976 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 4 | 76 | null | 78 | 26 | 36.59375 | 280.9375 | 4 | null | 0.799927 | 142 | 7.359375 | null | null | null | 1 | 0 | SIP>=30 | 0 |
38 | 41.97897 | 1 | male | 0 | 6 | 518 | CHF | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 5,552 | 3,679.8398 | null | 12 | white | 19.5 | 37 | 0.917969 | 0.860962 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 120 | 8.398438 | 86 | 22 | 37.5 | 295.1875 | null | null | 1.799805 | 129 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
39 | 19.79199 | 0 | male | 0 | 33 | 2,008 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 167,971 | null | null | 21.25 | black | 18.699219 | 5 | 0.932983 | 0.908936 | 4 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 33 | 83 | 9.599609 | 52 | 6 | 39 | 310 | null | null | null | 131 | 7.439453 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
40 | 57.50897 | 1 | female | 0 | 4 | 841 | CHF | COPD/CHF/Cirrhosis | 0 | 14 | under $11k | 0 | 6,403 | 3,672.0723 | null | 11 | black | 23.199219 | 27 | 0.849976 | 0.75293 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 4 | 83 | 14.298828 | 106 | 24 | 36.79688 | 280.9375 | null | null | 2.299805 | 138 | 7.449219 | null | null | null | 5 | 6 | SIP>=30 | 6 |
41 | 73.40698 | 0 | male | 0 | 9 | 2,007 | Colon Cancer | Cancer | 1 | null | null | 0 | 22,934 | 14,292.2656 | null | 12.5 | white | 11.599609 | 23 | 0.866943 | 0.701904 | 1 | 0 | 0 | metastatic | 0.9 | 0.4 | no dnr | 9 | 71 | 16.5 | 76 | 10 | 37 | null | 4 | 0.599976 | 0.799927 | 141 | null | null | null | null | null | null | null | 2.467773 |
42 | 68.31799 | 1 | male | 0 | 6 | 172 | Colon Cancer | Cancer | 1 | 21 | >$50k | 0 | 9,205 | 5,793.1914 | null | 11 | white | 14.898438 | 8 | 0.838989 | 0.645996 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 89 | 10.599609 | 92 | 18 | 39 | null | null | 0.5 | 1 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
43 | 75.79498 | 1 | female | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 271,250 | 136,387.875 | null | 42.333313 | white | 40 | 76 | 0.283997 | 0.174988 | 8 | 0 | 0 | no | null | null | dnr after sadm | 21 | 59 | 30.597656 | 90 | 22 | 37.5 | 70.90625 | 1.899902 | 5.399414 | 2.699707 | 128 | 7.329102 | null | null | null | null | null | <2 mo. follow-up | 2.685547 |
44 | 45.71899 | 0 | male | 0 | 20 | 2,006 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 115,112 | 61,771.0625 | null | 25.666656 | white | 21.796875 | 30 | 0.893921 | 0.821899 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 20 | 57 | 12.298828 | 96 | 22 | 36 | 185 | 3.899902 | null | 1.399902 | 135 | 7.599609 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
45 | 75.48798 | 1 | male | 0 | 36 | 79 | CHF | COPD/CHF/Cirrhosis | 1 | 16 | under $11k | 0 | 120,920 | 64,202.375 | null | 23.25 | hispanic | 32.296875 | 39 | 0.601929 | 0.412964 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 16 | 62 | 21.796875 | 102 | 24 | 36.59375 | 415 | null | null | 4 | 124 | 7.429688 | null | null | null | 2 | 0 | null | 0 |
46 | 74.995 | 1 | female | 1 | 25 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 348,931 | 173,763.5 | null | 43 | white | 35.695313 | 53 | 0.41095 | 0.290955 | 10 | 0 | 0 | no | null | null | dnr after sadm | 23 | 50 | 51.195313 | 120 | 18 | 36.19531 | 237.5 | 2.899902 | 1 | 4.799805 | 135 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.442383 |
47 | 56.19397 | 1 | male | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | null | 26 | 230,733 | 119,196 | null | 41.333313 | other | 36.695313 | 70 | 0.362 | 0.243988 | 15 | 0 | 0 | no | null | null | dnr after sadm | 20 | 68 | 26.699219 | 130 | 28 | 38.5 | 121.65625 | 1.699951 | 3.899902 | 2.099609 | 131 | 7.449219 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
48 | 44.849 | 1 | female | 0 | 12 | 229 | MOSF w/Malig | ARF/MOSF | 2 | 10 | $11-$25k | 0 | 25,176 | 12,210.7812 | null | 19.5 | hispanic | 24.796875 | 32 | 0.709961 | 0.620972 | 1 | 0 | 0 | yes | 0.6 | 0.4 | no dnr | 12 | 91 | 4.699219 | 70 | 32 | 37.09375 | 447.5625 | 2.299805 | 7 | 0.799927 | 136 | 7.359375 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
49 | 51.09698 | 1 | female | 0 | 19 | 489 | CHF | COPD/CHF/Cirrhosis | 1 | 11 | null | 0 | 30,877 | 17,287.9531 | null | 12 | black | 22.296875 | 43 | 0.876953 | 0.794922 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 19 | 100 | 5.699219 | 120 | 32 | 37.59375 | 203.6875 | 4.199219 | 0.199982 | 4 | 140 | 7.459961 | null | null | null | 2 | null | null | 1.839 |
50 | 36.30899 | 1 | male | 0 | 11 | 653 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 23,476 | 14,620.8047 | null | 15.5 | white | 26.097656 | 31 | 0.878906 | 0.797974 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 11 | 64 | 6.799805 | 115 | 20 | 36.29688 | null | 4.399414 | 4.5 | 1.299805 | 121 | null | null | null | null | 1 | 0 | null | 0 |
51 | 76.25696 | 0 | male | 0 | 9 | 2,001 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 14,926 | 8,138.4414 | null | 7.5 | white | 17.796875 | 32 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 9 | 74 | 9.298828 | 96 | 30 | 36.39844 | 266.625 | null | 1.099854 | 1.199951 | 141 | 7.399414 | null | null | null | 1 | 2 | null | 2 |
52 | 51.30499 | 1 | male | 0 | 25 | 162 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 52,187 | 30,876.375 | null | 11.75 | black | 26.097656 | 33 | 0.822998 | 0.711914 | 2 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 25 | 71 | null | 104 | 18 | 36.5 | null | null | null | 2.399902 | 128 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
53 | 74.54297 | 0 | female | 0 | 7 | 2,000 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 9,631 | 5,835.1602 | null | 8 | white | 22 | 23 | 0.78894 | 0.660889 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 83 | 14.199219 | 92 | 22 | 36.39844 | 164 | 3.299805 | 0.299988 | 0.799927 | 137 | 7.449219 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
54 | 54.30798 | 1 | male | 0 | 12 | 536 | Lung Cancer | Cancer | 1 | 17 | $25-$50k | 0 | 29,939 | 17,625.75 | null | 14.5 | white | 20.898438 | 8 | 0.650879 | 0.345947 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 12 | 95 | 11.599609 | 108 | 22 | 38 | 183 | null | null | 0.799927 | 136 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
55 | 77.57697 | 1 | female | 0 | 3 | 244 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 3,124 | 2,022.1035 | null | 6 | other | 17.296875 | 27 | 0.853882 | 0.758911 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 90 | 12.398438 | 84 | 32 | 36.59375 | 276.1875 | null | null | 0.799927 | 139 | 7.469727 | null | null | null | null | null | null | 2.308594 |
56 | 84.95795 | 0 | male | 0 | 17 | 1,998 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | >$50k | 0 | 30,942 | 18,401.7188 | null | 8.666664 | white | 14.099609 | 21 | 0.865967 | 0.777954 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 17 | 92 | 13.699219 | 80 | 32 | 37.19531 | 313.3125 | 3.799805 | 0.299988 | 1.299805 | 137 | 7.429688 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
57 | 41.52197 | 1 | male | 1 | 21 | 21 | MOSF w/Malig | ARF/MOSF | 2 | 18 | >$50k | 26 | 320,843 | 165,178.875 | null | 32.666657 | white | 36.09375 | 78 | 0.171997 | 0.08699 | 26 | 0 | 0 | yes | 0.1 | 0.001 | no dnr | 21 | 66 | 0.199982 | 130 | 18 | 37.5 | 315 | 1.899902 | 3.799805 | 7.299805 | 134 | 7.359375 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
58 | 39.685 | 0 | female | 0 | 35 | 1,995 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 22 | $25-$50k | 0 | 220,639 | 109,700.75 | null | 33 | white | 26 | 56 | 0.820923 | 0.759888 | 7 | 1 | 0 | no | 0.6 | 0.6 | no dnr | 35 | 62 | 36.695313 | 125 | 24 | 39.19531 | 208.5625 | 1.599854 | 0.399963 | 7.699219 | 139 | 7.399414 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
59 | 72.55896 | 1 | female | 1 | 4 | 4 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 4,894 | 3,078.6016 | null | 6 | white | 26 | 25 | 0.60791 | 0.419983 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 123 | 13.298828 | 98 | 32 | 37.19531 | 144.875 | null | null | 0.5 | 136 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 3.955078 |
60 | 60.10098 | 1 | male | 0 | 15 | 195 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 63,466 | 32,079.9531 | null | 27.666656 | white | 22.597656 | 40 | 0.746948 | 0.601929 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 110 | 6.299805 | 125 | 10 | 38.09375 | 208 | 2.799805 | 3.399902 | 1 | 142 | 7.439453 | null | null | null | null | null | null | 2.381348 |
61 | 70.81195 | 0 | male | 0 | 8 | 1,992 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 6,254 | 4,126.0742 | null | 5 | black | 16.199219 | 20 | 0.882935 | 0.804932 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 8 | 88 | 6.899414 | 80 | 22 | 37 | null | null | null | 1.799805 | 142 | null | null | null | null | null | null | null | 2.595703 |
62 | 30.76199 | 0 | male | 0 | 6 | 1,990 | CHF | COPD/CHF/Cirrhosis | 1 | 10 | under $11k | 0 | 8,437 | 5,632.8516 | null | 10 | hispanic | 24.5 | 37 | 0.903931 | 0.838989 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 6 | 70 | 6.599609 | 122 | 16 | 36.5 | 528.5 | null | null | 2.099609 | 133 | 7.459961 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
63 | 64.23798 | 1 | male | 0 | 61 | 974 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 321,716 | 162,087.25 | null | 34.5 | white | 26 | 32 | 0.738892 | 0.657959 | 5 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 61 | 68 | 9.5 | 122 | 12 | 38.69531 | 114 | null | null | 1.299805 | 136 | 7.319336 | null | null | null | null | 0 | null | 0 |
64 | 51.70999 | 0 | male | 0 | 12 | 1,987 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 31,222 | 18,348.2188 | null | 16 | asian | 18.796875 | 21 | 0.903931 | 0.838989 | 1 | 0 | 0 | no | 0.8 | 0.2 | no dnr | 12 | 50 | 6.699219 | 75 | 20 | 36.79688 | null | 3.699707 | null | 0.899902 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
65 | 64.64294 | 1 | male | 0 | 17 | 254 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 9 | 180,786 | 95,272.6875 | null | 25.333328 | white | 30.898438 | 49 | 0.554932 | 0.441956 | 17 | 1 | 0 | no | null | null | no dnr | 17 | 68 | 13.298828 | 92 | 38 | 38.79688 | 113.67188 | 3.399902 | 1.099854 | 2.299805 | 133 | 7.479492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
66 | 69.41498 | 1 | male | 0 | 6 | 101 | Lung Cancer | Cancer | 2 | 16 | $25-$50k | 26 | 8,706 | 5,389.1289 | null | 8 | white | 25.5 | 11 | 0.352966 | 0.075989 | 1 | 0 | 1 | metastatic | null | null | dnr after sadm | 2 | 109 | 5.299805 | 68 | 20 | 36.89844 | null | 2.699707 | null | 0.699951 | 133 | null | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
67 | 57.19098 | 1 | male | 0 | 9 | 42 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 28,476 | 17,331.0938 | null | 18 | white | 24.398438 | 42 | 0.836914 | 0.73291 | 1 | 0 | 0 | no | 0.3 | 0.1 | no dnr | 9 | 59 | 16 | 85 | 26 | 36.79688 | 204.75 | null | 0.5 | 0.799927 | 126 | 7.449219 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
68 | 37.73297 | 1 | male | 0 | 9 | 20 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $25-$50k | 0 | 26,278 | 14,961.0938 | null | 19 | white | 24.199219 | 23 | 0.891968 | 0.81897 | 1 | 0 | 0 | no | 0.2 | 0.05 | no dnr | 9 | 67 | 7.5 | 130 | 16 | 36.5 | 347.5625 | 3 | 0.599976 | 0.899902 | 132 | 7.469727 | null | null | null | 5 | 7 | <2 mo. follow-up | 7 |
69 | 44.05499 | 1 | female | 0 | 7 | 293 | Colon Cancer | Cancer | 0 | 16 | >$50k | 0 | 18,563 | 11,069.4688 | null | 8 | white | 12.898438 | 5 | 0.890991 | 0.751953 | 1 | 0 | 0 | metastatic | 1 | 0.7 | no dnr | 7 | 85 | 8.5 | 72 | 20 | 37.39844 | null | null | null | null | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
70 | 72.15594 | 0 | male | 0 | 35 | 1,984 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 26 | 187,014 | 95,392.75 | null | 27.25 | white | 24.699219 | 29 | 0.61792 | 0.512939 | 7 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 35 | 75 | 17.296875 | 120 | 24 | 38.29688 | 257.5 | 2.599609 | 4.899414 | 0.699951 | 135 | 7.5 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.70459 |
71 | 45.56598 | 1 | male | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 3 | 18 | $25-$50k | 0 | 181,701 | 92,664.625 | null | 51 | white | 69.296875 | 133 | 0 | 0 | 39 | 0 | 0 | yes | null | null | dnr after sadm | 3 | 33 | 0.299988 | 140 | 33 | 38.5 | 129 | 2.299805 | 31.398438 | 4.799805 | 142 | 7.359375 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
72 | 41.95999 | 1 | male | 0 | 4 | 503 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 4,173 | 2,648.0977 | null | 3 | white | 13.398438 | 7 | 0.813965 | 0.600952 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 4 | 97 | 10.798828 | 88 | 20 | 36.39844 | 380.9375 | 3.799805 | 0.5 | 1.099854 | 133 | 7.479492 | null | null | null | null | null | no(M2 and SIP pres) | 2.179688 |
73 | 59.31 | 0 | male | 0 | 72 | 1,981 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | >$50k | 26 | 538,692 | 301,788.5 | null | 32.5 | white | 37.796875 | 71 | 0.311951 | 0.198975 | 13 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 72 | 60 | 19.398438 | 160 | 38 | 37.29688 | 113.32812 | 3.099609 | 13.099609 | 1.299805 | 142 | 7.509766 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
74 | 45.61499 | 1 | female | 1 | 44 | 44 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 16 | >$50k | 44 | 302,353 | 155,929.75 | null | 30.5 | white | 27.199219 | 55 | 0.5979 | 0.406982 | 1 | 0 | 0 | no | 0.3 | 0.25 | dnr after sadm | 41 | 57 | 13.599609 | 112 | 28 | 38.59375 | 134.4375 | 1.699951 | 1.5 | 0.899902 | 139 | 7.179688 | null | null | null | null | null | <2 mo. follow-up | 3.54541 |
75 | 65.98499 | 1 | female | 0 | 10 | 540 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 18,980 | 9,559.2266 | null | 13.5 | hispanic | 11.099609 | 19 | 0.880981 | 0.730957 | 1 | 1 | 0 | metastatic | null | null | no dnr | 10 | 127 | 17.796875 | 96 | 26 | 38.89844 | 372 | 4.099609 | 0.299988 | 0.799927 | 140 | 7.399414 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
76 | 95.79199 | 1 | female | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 44 | 74,764 | 36,613.2812 | null | 29 | white | 19.199219 | 18 | 0.610962 | 0.504883 | 1 | 0 | 1 | no | null | null | dnr after sadm | 16 | 88 | 11.599609 | 65 | 8 | 37.19531 | 360 | 2.599609 | null | 1.699951 | 147 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 5.941406 |
77 | 76.59094 | 1 | male | 0 | 8 | 142 | Colon Cancer | Cancer | 1 | 17 | $11-$25k | 0 | 7,137 | 4,350.3672 | null | 4.5 | white | 7.799805 | 6 | 0.896973 | 0.762939 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 83 | 12.798828 | 76 | 18 | 38.29688 | 390.4375 | 4.099609 | 0.799927 | 0.799927 | 146 | 7.439453 | null | null | null | 1 | 2 | null | 2 |
78 | 68.10095 | 0 | male | 0 | 4 | 1,979 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 9,586 | 5,151.0469 | null | 7 | white | 17.898438 | 33 | 0.873901 | 0.790894 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 4 | 72 | 5.899414 | 80 | 18 | 36.79688 | null | null | null | 2.199707 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.971924 |
79 | 78.85297 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 37 | 39,420 | 20,195.5781 | null | 27 | white | 21.5 | 30 | 0.642944 | 0.541992 | 3 | 0 | 1 | no | null | null | dnr after sadm | 4 | 60 | 36.195313 | 112 | 11 | 36.59375 | 214.28125 | null | 1.099854 | 1.099854 | 137 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 4.947266 |
80 | 37.87 | 0 | male | 0 | 120 | 1,977 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 397,017 | 207,528.5 | null | 31 | white | 31.097656 | 48 | 0.703979 | 0.61499 | 14 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 120 | 83 | 23.5 | 122 | 26 | 37.59375 | 257.5 | null | 3.099609 | 5.199219 | 134 | 7.379883 | null | null | null | null | null | null | 2.540039 |
81 | 74.90997 | 1 | female | 0 | 6 | 18 | COPD | COPD/CHF/Cirrhosis | 1 | 16 | null | 0 | 8,166 | 4,166.6992 | null | 8 | white | 15.599609 | 9 | 0.866943 | 0.779907 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 6 | 106 | 11.398438 | 84 | 22 | 37 | 424 | null | null | 0.799927 | 142 | 7.399414 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
82 | 31.702 | 0 | female | 0 | 49 | 1,973 | Cirrhosis | COPD/CHF/Cirrhosis | 0 | 14 | null | 0 | 231,119 | 101,867.938 | null | 15.5 | black | 20.097656 | 24 | 0.903931 | 0.837891 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 49 | 77 | 7.699219 | 80 | 20 | 37.19531 | 490.4375 | 2.199707 | 2.699707 | 1.399902 | 127 | 7.489258 | null | null | null | 6 | 1 | SIP>=30 | 1 |
83 | 54.93997 | 1 | female | 0 | 10 | 55 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $11-$25k | 0 | 27,561 | 15,429.6172 | null | 21 | white | 20.199219 | 22 | 0.885986 | 0.80896 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 55 | 6.199219 | 104 | 24 | 36.79688 | 504 | 3.599609 | 1.099854 | 0.799927 | 136 | 7.459961 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
84 | 43.30197 | 1 | male | 1 | 39 | 39 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 283,145 | 108,597.562 | null | 13.75 | hispanic | 23.597656 | 33 | 0.826904 | 0.716919 | 1 | 0 | 0 | no | null | null | no dnr | 39 | 83 | 10 | 80 | 20 | 37 | null | 2.099609 | 13 | 1 | 130 | null | null | null | null | 3 | 2 | <2 mo. follow-up | 2 |
85 | 54.92999 | 1 | female | 0 | 8 | 50 | Lung Cancer | Cancer | 0 | 12 | $25-$50k | 0 | 15,392 | 7,098.3008 | null | 10 | asian | 22 | 25 | 0.625977 | 0.312988 | 1 | 0 | 0 | metastatic | null | null | no dnr | 8 | 143 | 10.699219 | 84 | 40 | 36.19531 | null | 3.299805 | null | 0.799927 | 135 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
86 | 70.21497 | 1 | male | 0 | 7 | 173 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 8,442 | 5,144.7188 | null | 11.5 | white | 25.398438 | 27 | 0.653931 | 0.348999 | 1 | 1 | 0 | metastatic | 0.9 | 0.5 | no dnr | 7 | 117 | 10.199219 | 22 | 18 | 38 | null | 3.099609 | 0.699951 | 1.299805 | 137 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
87 | 67.09399 | 0 | female | 0 | 27 | 1,969 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 3 | under $11k | 0 | 71,992 | 37,093.125 | null | 17.5 | black | 23.199219 | 28 | 0.68689 | 0.518921 | 1 | 0 | 0 | no | null | null | dnr after sadm | 5 | 104 | 21.796875 | 82 | 20 | 37 | null | 2 | 6.599609 | 0.599976 | 135 | null | null | null | null | null | 1 | null | 1 |
88 | 65.05096 | 1 | male | 0 | 10 | 125 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 14 | $25-$50k | 0 | 14,944 | 9,489.5391 | null | 9 | white | 27.796875 | 36 | 0.5979 | 0.407959 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 77 | 12.099609 | 72 | 22 | 36.39844 | null | 2.5 | 21.699219 | 1.199951 | 130 | null | null | null | null | 0 | 2 | null | 2 |
89 | 69.34698 | 1 | male | 1 | 42 | 42 | MOSF w/Malig | ARF/MOSF | 2 | 18 | null | 0 | 433,684 | 214,329.25 | null | 38.25 | asian | 25.398438 | 27 | 0.492981 | 0.375 | 11 | 1 | 0 | metastatic | null | null | no dnr | 42 | 112 | 10.398438 | 125 | 14 | 36.5 | 274.25 | 3.799805 | 5.699219 | 1.099854 | 140 | 7.449219 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
90 | 64.98798 | 1 | female | 0 | 4 | 33 | Lung Cancer | Cancer | 0 | null | null | 0 | 8,137 | 4,735.9922 | null | 9 | white | 18.296875 | 11 | 0.680908 | 0.385986 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 110 | 18.796875 | 80 | 20 | 36.39844 | null | null | null | 0.699951 | 134 | null | null | null | null | null | null | <2 mo. follow-up | 2.198731 |
91 | 80.62097 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 104,163 | 53,111.3125 | null | 38 | white | 35.898438 | 77 | 0.167999 | 0.084991 | 14 | 0 | 0 | no | null | null | dnr after sadm | 2 | 61 | 23 | 140 | 32 | 39.19531 | 75.54688 | 2.299805 | 1.5 | 1.899902 | 135 | 7.129883 | null | null | null | null | null | <2 mo. follow-up | 3.361816 |
92 | 72.172 | 1 | male | 1 | 12 | 12 | Lung Cancer | Cancer | 1 | null | null | 0 | 62,158 | 31,507.8125 | null | 25 | white | 34.195313 | 47 | 0.222992 | 0.023998 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | no dnr | 12 | 63 | 5.099609 | 140 | 36 | 36.5 | 176.65625 | 2.699707 | null | 1.099854 | 135 | 7.55957 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
93 | 53.06198 | 1 | male | 0 | 3 | 28 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 6,734 | 3,384.6172 | null | 4 | white | 19.296875 | 28 | 0.890991 | 0.817993 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 77 | 10.898438 | 72 | 24 | 36.39844 | 280.9375 | 3.899902 | null | 0.799927 | 126 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 2.619141 |
94 | 52.50699 | 1 | female | 1 | 6 | 6 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 20,735 | 11,022.1016 | null | 9 | white | 20.898438 | 24 | 0.884888 | 0.80896 | 1 | 1 | 0 | no | 0.6 | 0.2 | dnr after sadm | 6 | 67 | 8.5 | 88 | 20 | 36.59375 | null | 3.099609 | 0.699951 | 1.399902 | 129 | null | null | null | null | 6 | 7 | <2 mo. follow-up | 7 |
95 | 74.97095 | 1 | male | 0 | 19 | 259 | Colon Cancer | Cancer | 0 | null | null | 0 | 43,009 | 22,430.0625 | null | 12.333328 | white | 3.299805 | 26 | 0.928955 | 0.832886 | 1 | 0 | 0 | metastatic | 0.9 | 0.85 | no dnr | 19 | 91 | 6.799805 | 88 | 20 | 36.79688 | null | 4.599609 | 2.5 | 1.099854 | 142 | null | null | null | null | null | null | null | 1.91626 |
96 | 53.34998 | 1 | male | 0 | 52 | 126 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 17 | >$50k | 26 | 483,991 | 285,715.25 | null | 39 | asian | 40.5 | 71 | 0.286987 | 0.176971 | 9 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 52 | 73 | 19.5 | 158 | 36 | 39.29688 | 187.5 | 3.599609 | 11.099609 | 2.699707 | 154 | 7.369141 | null | null | null | null | 6 | null | 6 |
97 | 89.58795 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 100 | 19,238 | 9,710.9062 | null | 34 | white | 54.898438 | 80 | 0 | 0 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 33 | 13.699219 | 0 | 0 | 38.5 | 122 | 2.299805 | 0.5 | 1 | 130 | 7.289062 | null | null | null | null | null | <2 mo. follow-up | 5.568359 |
98 | 56.62399 | 1 | male | 0 | 11 | 559 | Colon Cancer | Cancer | 0 | 12 | >$50k | 0 | 27,408 | 15,270.6484 | null | 12 | white | 5.699219 | 12 | 0.928955 | 0.833984 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 116 | 8.199219 | 102 | 18 | 38.39844 | null | 4.299805 | 0.299988 | 1.199951 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
99 | 75.04199 | 1 | male | 0 | 6 | 123 | Colon Cancer | Cancer | 0 | 16 | null | 0 | 8,723 | 5,835.2305 | null | 16 | hispanic | 35.898438 | 47 | 0.35199 | 0.074997 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 123 | 16.296875 | 112 | 28 | 36 | 352.375 | 2.899902 | 1.699951 | 7.599609 | 134 | 7.479492 | null | null | null | null | null | SIP>=30 | 2.249512 |
100 | 75.76196 | 0 | male | 0 | 21 | 1,962 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 74,162 | 40,581 | null | 23.666656 | white | 22.699219 | 28 | 0.734985 | 0.652954 | 8 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 21 | 68 | 16.597656 | 79 | 20 | 37.19531 | 132.71875 | null | null | 1.099854 | 132 | 7.489258 | null | null | null | 0 | null | null | 0.4948 |